Table 1.

Patients with a diagnosis of primary HLH

PatientAge/sexNK LU%% perforinNucleotide changeAmino acid change
NKCD8CD56
P9 3 mo/F 0.00↓ 2↓ 0↓ 0↓ 50delT* Leu17X 
P11 8 mo/M 0.00↓ 0↓ 0↓ 50delT* Leu17X 
P10 3 y/F 0.12↓ 61↓ 0↓ 0↓ 133G>A Gly45Arg 
       160C>T Arg54Ser 
P1 10 y/F 0.01↓ 18 1↓ 0↓ 0↓ 116C>A Pro39His 
       445G>A Gly149Ser 
P6 2 mo/F 0.00↓ 39 96 31 No mutation  
P7 4 mo/F 0.00↓ 1↓ 83 No mutation  
P2 7 mo/F 0.00↓ 21 91 25 No mutation  
Normal values 0-1 y   3 -17 91-97 0-3   4-30   
  >3.2       
 1-15 y  4-22 81-91 2-11 12-34   
PatientAge/sexNK LU%% perforinNucleotide changeAmino acid change
NKCD8CD56
P9 3 mo/F 0.00↓ 2↓ 0↓ 0↓ 50delT* Leu17X 
P11 8 mo/M 0.00↓ 0↓ 0↓ 50delT* Leu17X 
P10 3 y/F 0.12↓ 61↓ 0↓ 0↓ 133G>A Gly45Arg 
       160C>T Arg54Ser 
P1 10 y/F 0.01↓ 18 1↓ 0↓ 0↓ 116C>A Pro39His 
       445G>A Gly149Ser 
P6 2 mo/F 0.00↓ 39 96 31 No mutation  
P7 4 mo/F 0.00↓ 1↓ 83 No mutation  
P2 7 mo/F 0.00↓ 21 91 25 No mutation  
Normal values 0-1 y   3 -17 91-97 0-3   4-30   
  >3.2       
 1-15 y  4-22 81-91 2-11 12-34   

All patients demonstrated absent NK function. Patients P1, P9, and P11 showed lack of intracellular perforin in all cytotoxic cell types (complete deficiency). Patient P10 showed lack of intracellular perforin in CD8+ and CD56+ T cells and a very low positivity of perforin staining in the NK cells (partial deficiency). The other three patients with presumed primary HLH had normal percentages of perforin positive cytotoxic cells for age.

*

Homozygous mutation.

Heterozygous mutation.

Close Modal

or Create an Account

Close Modal
Close Modal